Previous Article | Next Article 
Mol Cell Biol, January 1998, p. 400-408, Vol. 18, No. 1
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Activation of the Kexin from Schizosaccharomyces pombe
Requires Internal Cleavage of Its Initially Cleaved
Prosequence
Dale
Powner and
John
Davey*
Department of Biological Sciences, University
of Warwick, Coventry CV4 7AL, United Kingdom
Received 15 July 1997/Returned for modification 4 September
1997/Accepted 15 October 1997
 |
ABSTRACT |
Members of the kexin family of processing enzymes are responsible
for the cleavage of many proproteins during their transport through the
secretory pathway. The enzymes themselves are made as inactive
precursors, and we investigated the activation process by studying the
maturation of Krp1, a kexin from the fission yeast Schizosaccharomyces pombe. Using a cell-free
translation-translocation system prepared from Xenopus
eggs, we found that Krp1 is made as a preproprotein that loses the
presequence during translocation into the endoplasmic reticulum. The
prosequence is also rapidly cleaved in a reaction that is autocatalytic
and probably intramolecular and is inhibited by disruption of the P
domain. Prosequence cleavage normally occurs at
Arg-Tyr-Lys-Arg102
(primary cleavage site) but can occur at
Lys-Arg82 (internal cleavage site) and/or Trp-Arg99 when the
basic residues are removed from the primary site. Cleavage of the
prosequence is necessary but not sufficient for activation, and Krp1 is
initially unable to process substrates presented in trans.
Full activation is achieved after further incubation in the extract and
is coincident with the addition of O-linked sugars. O glycosylation is
not, however, essential for activity, and the crucial event appears to
be cleavage of the initially cleaved prosequence at the internal site.
Our results are consistent with a model in which the cleaved
prosequence remains noncovalently associated with the catalytic domain
and acts as an autoinhibitor of the enzyme. Inhibition is then relieved
by a second (internal) cleavage of the inhibitory prosequence. Further
support for this model is provided by our finding that overexpression
of a Krp1 prosequence lacking a cleavable internal site dramatically
reduced the growth rate of otherwise wild-type S. pombe
cells, an effect that was not seen after overexpression of the normal,
internally cleavable, prosequence or prosequences that lack the
Lys-Arg102 residues.
 |
INTRODUCTION |
The maturation of prohormones and
propolypeptides often involves cleavage at pairs of basic residues as
the precursor is transported through the secretory pathway. In many
cases, cleavage is performed by a member of the prohormone convertase
or kexin family of endopeptidases (the Kex2 protease from
Saccharomyces cerevisiae was the first member of the family
to be characterized) (for a review, see reference 45). The kexins themselves are also made as inactive
precursors, and there has been considerable interest in defining the
mechanism by which they are activated. The process has been studied in
systems that include mammalian cells, yeast, Xenopus
oocytes, and cell extracts, and the activation mechanism is thought to
be broadly similar for each member of the family. All are synthesized
with an amino-terminal presequence, a prosequence, a subtilisin-like catalytic domain, a P domain (12, 15), and a
carboxy-terminal region that may (e.g., Krp1, Kex2, and furin) or may
not contain a hydrophobic transmembrane domain (Fig.
1). The presequence directs the precursor
to the secretory pathway and is removed during segregation into the
endoplasmic reticulum (ER). The prosequence is presumed to play a role
in the correct folding of the catalytic domain and is usually removed
in the ER (7, 31, 49) in a reaction that is believed to be
autocatalytic and probably intramolecular (6, 16, 29),
although intermolecular cleavage can occur (29). The mature
enzyme is then transported along the secretory pathway to its site of
action.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic of Krp1. Krp1 is a type I membrane protein
with an N-terminal presequence (diagonal lines), a single transmembrane
domain (wavy lines), and a short cytoplasmic domain (residues 696 to
709). The residues at the end of the prosequence are shown to highlight
the location of the primary (Lys-Arg102) and internal (Lys-Arg82)
cleavage sites. The locations of residues used to truncate Krp1 are
also indicated (Y611, R667, and K696). There are five potential sites
for N glycosylation (lollipops) and a Ser/Thr-rich region (light
shading just N terminal of the transmembrane domain) with several
potential sites for O glycosylation. The catalytic domain contains the
active-site residues (Asp, His, Asn, and Ser) and is followed by the P
domain (dark shading), a region of high sequence homology between
members of the kexin family (15); residues near the
predicted C terminus of the P domain are shown for comparison. S. pombe (Sp) Krp1 (8), Saccharomyces
cerevisiae (Sc) Kex2 (10),
Kluyveromyces lactis (Kl) Kex1 (46),
Mus musculus (Mm) PC6 (33), Homo
sapiens (Hs) PACE4 (20), Drosophila
melanogaster (Dm) fur1 (36), Dm
fur2 (37), Hs PC2 (43), Hs
PC3 (= PC1) (44), Hs PC7 (= PC8) (3),
Hs fur1 (48), X. laevis
(Xl) fur1 (21), and Mm PC4
(34) sequences are shown. AAs, amino acids.
|
|
Prosequence cleavage at the primary cleavage site is necessary for the
kexin to become active but is not sufficient for activation, and
additional steps are required before the enzyme is able to cleave
substrates presented in trans (7, 31). The first
insights into the nature of these additional steps came not from kexins but from studies of the bacterial serine proteinases subtilisin and
-lytic protease. These enzymes are evolutionarily related to the
eukaryotic kexins and are also synthesized with an N-terminal prosequence that facilitates correct folding of the protein before being removed by intramolecular cleavage (18, 35, 42, 52). The cleaved prosequence is not released from the enzyme but remains noncovalently associated with the catalytic domain and acts as an
autoinhibitor (4, 13, 25, 26). The enzyme is able to become
fully active only when the prosequence is degraded (18). A
recent study of furin maturation suggests that the prosequence plays a
similar inhibitory role in the activation of kexins (1). To
investigate whether the cleaved prosequence plays a role in the
activation of other kexins, we studied the maturation of Krp1, a kexin
from the fission yeast Schizosaccharomyces pombe
(8). Because Krp1 is an essential enzyme and its
overexpression is also lethal (8), it has not been possible
to perform these studies in its normal environment within the cell.
Maturation has therefore been studied in vitro by using a coupled
translation-translocation system prepared from Xenopus
laevis eggs (28, 29), a system that has proved
invaluable for the analysis of other members of the kexin family
(29, 39). We found that prosequence cleavage is
autocatalytic and probably intramolecular and that the efficiency of
this reaction is influenced by both the sequence at the cleavage site
and by the integrity of other parts of the protein. The cleaved prosequence seems to inhibit the activation of Krp1, and the enzyme is
able to become fully active only after an additional, internal cleavage
of the prosequence. Further support for this model comes from in vivo
analysis, showing that overexpression of a mutant prosequence lacking
the internal cleavage site inhibited the growth of otherwise wild-type
yeast cells, presumably via inhibition of Krp1. Our results are similar
to those reported for furin, although there are some differences
between the two enzymes and the significance of these is discussed.
 |
MATERIALS AND METHODS |
Krp1 constructs.
The starting template for constructing
various mutants was a 2,320-bp EcoRV-SnaBI
fragment containing the entire coding region of the krp1
gene (8). The SnaBI restriction site lies just downstream of the stop codon, whereas the EcoRV site was
introduced immediately upstream of the initiator codon by PCR with
primer JO95 (5'-GGGATATCCCAGCACCATGCATCC-3'
[the EcoRV site is underlined, and the initiator ATG
is shown in boldface]). All PCRs used Pwo DNA polymerase
(from Pyrococcus woesei; supplied by Boehringer Mannheim,
Lewes, East Sussex, United Kingdom), as this has a 3'-5' exonuclease,
or proofreading, activity and greatly reduces the introduction of
errors during amplification. All constructs were sequenced by the
dideoxynucleotide method with double-stranded DNA to confirm that only
the appropriate changes had been introduced.
Truncated forms of Krp1 were generated by PCR with JO95 as the sense
primer and an appropriate antisense primer that included
two stop
anticodons (TCATCA [shown in boldface]) and an
EcoRV
restriction site (underlined);
JO617(5'-GG
GATATCATCACCAATTTTCAAACGTACC-3')
for Krp1[W578*],JO616
(5'-GG
GATATCATCACAACTGCCAATTTTCAAACG-3')
for Krp1[L580*], JO618
(5'-GG
GATATCATCACAAAGCCAACTGCCAATTTTC-3')
for Krp1[L582*], JO615
(5'-GG
GATATCATCACCACAAAGCCAACTGCCAA-3')
for Krp1[W583*], JO516
(5'-GG
GATATCATCATCCCCACAAAGCCAACTG-3')
for Krp1[G584*], JO517
(5'-GG
GATATCATCATTCTCCCCACAAAGCCAAC-3')
for Krp1[E585*], JO613
(5'-GG
GATATCATCAAGAAGGGTTTTCAGATTCTCCC-3')
for Krp1[S590*], JO518
(5'-GG
GATATCATCAGTATATTCCCAAGACCATC-3')
for Krp1[Y611*], JO519
(5'-GG
GATATCATCATCTATAAGAGGGTTCCAATAC-3')
for Krp1[Y667*], JO520
(5'-GG
GATATCATCATTTCCAAAATGCGGAAATCC-3')
for Krp1[K696*], JO456
(5'-GG
GATATCATCATCGTTTTCGAATTGAACTTTG-3') for Krp1[R82*],JO457
(5'-GG
GA TATCATCAGCGCCATCTGGGCGTCTGGGC-3')
forKrp1[R99*],
and JO458
(5'-GG
GATATCATCACCGCTTGTAGCGCCATCTGGG-3')
for Krp1[R102*]. The PCR products were digested with
EcoRV and
cloned into pBluescript-KS (Stratagene Ltd.,
Cambridge, United
Kingdom).
To change Ser371 to Ala, we took advantage of a
KpnI
restriction site immediately upstream of the appropriate codon in the
krp1 gene and designed a sense primer that incorporated this
restriction
site and the necessary TCA-to-GCA change (JO459 is
5'-GGT
GGTACCGCAGCGGCTGC-3',
where the
KpnI site is underlined and the T-to-G mutation is shown
in
boldface). JO459 and JO66 (an antisense primer that lies downstream
of
the
SnaBI site) were used to amplify the C terminus of
krp1,
and this was then digested with
KpnI and
SnaBI. The mutated fragment
was exchanged for the equivalent
region from the wild-type
krp1 gene to produce
krp1S371A.
Changes to the basic residues at the primary and/or internal cleavage
sites were achieved by exploiting the
EcoRV site that
we had
previously introduced immediately upstream of the initiator
ATG (with
JO95) and a unique
BamHI site that corresponds to codons
122 to 124 of the
krp1 open reading frame. This region can be
amplified with JO95 and JO58 (antisense to a region just downstream
of
the
BamHI site). The mutation of Arg102 to Ala was therefore
achieved by first amplifying upstream regions with JO95 and JO420
(5'-ACTCGCATC
CGCCTTGTAGCG-3'; antisense primer
that changes
the Arg102 anticodon from CCG to CGC [shown in bold] for
Ala)
and then amplifying C-terminal regions with JO419
(5'-CGCTACAAG
GCGGATGCGAGT-3';
sense primer that
changes the Arg102 codon from CGG to GCG [shown
in bold] for Ala) and
JO58. The products from these individual
reactions were mixed and
amplified with JO95 and JO58 to generate
the full-length
EcoRV-
BamHI fragment containing the Arg102-to-Ala
mutation. This was then exchanged for the equivalent fragment
from the
wild-type
krp1 gene to give
krp1[KR82][KA102]. The Arg102-to-Lys
change was made in
the same way by using JO349
(5'-CGCTACAAG
AAGGATGCGAGT-3';
changes the CGG
codon to AAG [shown in boldface]) as the sense
primer and JO350
(5'-ACTCGCATC
CTTCTTGTAGCG-3'; changes
the CCG
anticodon to CTT [shown in boldface]) as the antisense
primer.
Mutations at the internal site took advantage of a unique
BstBI site immediately upstream of the appropriate region in
the
krp1 gene. We therefore designed sense primers that
incorporated
the
BstBI site and made the appropriate change
at the internal
cleavage site. A PCR with the relevant primer and JO58
(see above)
therefore amplifies a mutated
BstBI-
BamHI fragment that can then
be exchanged
for the equivalent fragment of the
krp1 gene. By
using
constructs already containing appropriate mutations at the
primary
cleavage site, we were able to prepare constructs mutated
at both
sites. The following two sense primers were used to make
the changes at
the internal site (the changed codons [Lys81 is
normally AAA, and
Arg82 is normally CGA] are shown in boldface,
and the
BstBI
site is underlined): JO426
(5'-GTTCAA
TTCGAAAA
GCCGGCATTGATGCC-3')
for Krp1[KA82] and JO427
(5'-GTTCAA
TTCGAATTGCCGGCATTGATGCC-3')
for Krp1[IA82].
All oligonucleotides were synthesized on an automatic synthesizer
(model BT8510; Biotech Instruments) by using the materials
and
conditions recommended by the manufacturer. (This work was
performed by
Alta Bioscience at The University of Birmingham,
Birmingham, United
Kingdom.)
In vitro transcription.
mRNA was synthesized in an in vitro
transcription reaction with SP6 RNA polymerase and templates produced
by subcloning the required Krp1 constructs into vector pSP64T
(22). Transcription reactions were performed as described
previously (28). The construction of pSP64Tmap2 has already
been described (8); the map2 gene encodes the
precursor of the S. pombe P-factor mating pheromone (19).
Xenopus egg extract.
Xenopus egg extract
was prepared as described previously (28). Translations were
initiated by adding mRNA (final concentration, 100 µg/ml) to an
aliquot of extract containing 10% (vol/vol) nuclease-treated rabbit
reticulocyte lysate (Promega, Southampton, United Kingdom), 10 µM
creatine phosphate, 0.2 µM spermidine, and 2 mCi of
[3H]leucine (130 Ci/mmol) (Amersham International, Little
Chalfont, Buckinghamshire, United Kingdom) per ml. All samples were
incubated at 21°C for 1 h. When required, cycloheximide was
added to a final concentration of 2 mM to inhibit further translation,
and the incubation was continued at 21°C. The analysis of catalytic
fragments by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) was performed as described previously (28, 29),
and cleaved prosequences were separated on a 15% peptide gel by using
an SDS-Tris-tricine buffer system (38). Quantitative
analysis of the amount of Krp1-related material was made by using a
PhosphorImager (Molecular Dynamics) with ImageQuant software.
N-terminal radiosequencing was performed as described previously
(8). Briefly, proteins were transferred to a polyvinylidene
difluoride (PVDF) membrane with a semidry blotter and the appropriate
section of the membrane (identified by autoradiography) was excised and
subjected to cycle sequencing in an ABI 473A protein sequencer (Applied
Biosystems) (this was performed by Alta Bioscience, University of
Birmingham). The injection of Xenopus laevis oocytes with
Krp1 mRNA or a control mRNA (Map2 mRNA) and the preparation of membrane
extracts for incubation with Krp1S371A were performed as described
previously (8).
Krp1 activity assays.
Samples of extract containing
translated Krp1 were diluted by the addition of ice-cold 100 mM HEPES
(pH 6.5)-2 mM CaCl2-1 mM phenylmethylsulfonyl fluoride-1
mM tosyl-L-phenylalanine chloromethyl ketone to osmotically
lyse membrane vesicles. These were collected by centrifugation at full
speed in a microcentrifuge at 4°C, and the pellets were resuspended
in assay buffer (100 mM HEPES [pH 6.5], 2 mM CaCl2, 0.5%
Triton X-100, 1 mM phenylmethylsulfonyl fluoride, and 1 mM
tosyl-L-phenylalanine chloromethyl ketone). Reaction
mixtures were assembled in two halves, with one half containing
membranes from the extract and the other containing the fluorogenic
peptide Boc.Arg-Thr-Lys-Arg-4-methyl-comaryl-7-amide (MCA) (Peptides
Institute Inc., Louisville, Ky.) at 100 µM. All reactions were
performed at 29°C, and both halves were preincubated at this
temperature for 5 min before mixing. The increase in fluorescence was
monitored with a luminescence spectrometer (model LS-5; Perkin-Elmer) at an excitation wavelength of 365 nm and an emission wavelength of 460 nm.
Expressing prosequence constructs in S. pombe.
The
prosequence regions of relevant Krp1 constructs were amplified by a PCR
approach similar to that described above for generating truncated forms
of Krp1. Briefly, sense primer JO638 introduced a BamHI
restriction site just upstream of the initiator ATG
(5'-GGGGGATCCAGCACCATGCATCCTGCTTTGC-3' [the BamHI site is underlined, and the initiator ATG
is shown in bold]) and a stop anticodon (TCA [shown in bold]) and a
BamHI restriction site (underlined) were introduced at the
required positions with the appropriate antisense primer, JO458
(5'-GGGGATCCTCACCGCTTGTAGCGCCATCTG-3') for prosequences that terminate immediately after Arg102
(Krp1[R102*]) and JO451
(5'-CCGGATCCTCAGTAGCGCCATCTGGGCG-3')
for prosequences that terminate after Tyr100 (Krp1[Y100*]). By
using different Krp1 constructs as templates for PCR, we were able to
generate prosequences with different motifs at the internal cleavage
site ([KR82] and [KA82]). The PCR products were cloned into the
BamHI site of expression vector pREP3X (30),
sequenced to confirm that only the appropriate changes had been
introduced, and transformed into S. pombe JY330 (a
heterothallic haploid strain of the Plus mating type). Transformants
were cultured in either minimal medium or minimal medium lacking
thiamine to induce expression from the nmt1 promoter
(30). All yeast procedures were performed by standard methods (32).
 |
RESULTS |
Primary cleavage of the prosequence is autocatalytic.
A 1-h
translation of Krp1 mRNA in Xenopus egg extract generated
two products (Fig. 2, lane 1). We had
previously used radiosequencing to show that the smaller polypeptide
(apparent Mr of ~76,000) is the C-terminal
portion of Krp1 generated by cleavage after Lys-Arg102 (8),
and we believe that the other product (apparent Mr of ~90,000) is proKrp1 (i.e., Krp1 that
lacks the presequence but still contains its prosequence). To
investigate whether cleavage of the prosequence is autocatalytic, we
used site-directed mutagenesis to change Ser371 to Ala (a product
referred to as Krp1S371A). A sequence comparison with other related
enzymes indicated that Ser371 of Krp1 is likely to form an essential
part of the active site, and if so, Krp1S371A would be expected to be
catalytically inactive (14, 15, 40). Therefore, the fact
that translation of Krp1S371A mRNA in Xenopus egg extract
produced only proKrp1 (Fig. 2, lane 2) suggests that prosequence
cleavage at the primary site is an autocatalytic event. To
confirm that Krp1 can cleave the prosequence from proKrp1, we mixed the
product from Krp1S371A with membranes prepared from
Xenopus oocytes that had been injected with Krp1 mRNA (Fig.
2, lane 3). These membranes provide a source of active Krp1 that is
relatively free from related proteases (8), and the
conversion of proKrp1 to Krp1 demonstrates that Krp1 can cleave its own
prosequence through an intermolecular interaction.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Prosequence cleavage is autocatalytic. Krp1S371A or
Krp1[IA82][KK102]S371A mRNA was translated in
Xenopus egg extract for 1 h in the presence of
[3H]leucine and was then mixed in the presence of 1%
Triton X-100 with membrane extracts prepared from Xenopus
oocytes that had been injected with either a control mRNA (lanes 2 and
5) or Krp1 mRNA (lanes 3 and 6). The digestion products were separated
by SDS-PAGE. Lane 1 is included to aid interpretation. It contained the
products obtained from a 1-h translation of Krp1 mRNA in egg extract;
the products are proKrp1 (upper band) and Krp1 (lower band). Lane 4 was
from a 1-h translation of Krp1[IA82][KK102] mRNA and
demonstrates that the Lys-Lys102 motif at the primary cleavage site is
cleaved in an active form of Krp1. The positions of molecular weight
markers (in thousands) are shown on the left.
|
|
We took advantage of the inability of Krp1S371A to remove its own
prosequence to identify the site of presequence cleavage.
Krp1S371A
mRNA was translated in egg extract, and proKrp1S371A
was transferred to
a PVDF membrane before being subjected to amino
acid sequencing
(
8). Peaks of [
3H]leucine were
observed in cycles 4, 9, and 11 (not shown), which
suggests a
presequence that is cleaved after Ser23 in the sequence
Val-Ser-Ser23-Cys-Ser-Pro.
N-terminal requirements for prosequence cleavage.
A striking
feature of the prosequences of most kexins, including Krp1, is the
presence of two distinct clusters of basic amino acids (41).
One cluster (Arg-XXX-Lys-Arg) is the position that we have identified
as the site of initial cleavage of the Krp1 prosequence (8)
and others have shown to be the site of prosequence cleavage in furin
(7, 24, 31, 49), Kex2 (2, 51), PC2
(29), and PC3 (16, 27, 50). This is often
referred to as the primary cleavage site. The second cluster of basic
residues has been studied less extensively, and until recently (see
below), there has been no convincing evidence of cleavage at this
internal site. We therefore decided to investigate cleavage in more
detail by generating mutant forms of Krp1 that lack the normal basic motifs at either or both of these sites and analyzing the effects in
Xenopus egg extract (Fig. 3).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 3.
N-terminal requirements for prosequence cleavage. (A)
Krp1 mRNA and mRNAs from various Krp1 mutants that lack the normal
basic motifs at either the primary or internal site were translated in
Xenopus egg extract for 1 h in the presence of
[3H]leucine before being analyzed by SDS-PAGE on a
low-percentage gel (lanes 1 to 9). Krp1[IA82][KA102] mRNA
was also translated for 6 h before analysis in order to
investigate the slow processing of this mutant (lane 10). The positions
of molecular weight markers (in thousands) are shown on the left. (B)
Selected samples were also analyzed on a high-percentage acrylamide gel
(38). To aid in the interpretation of prosequence fragments,
we prepared versions of Krp1 with stop codons introduced immediately
after Arg102 (Krp1[R102*]), Arg99 (Krp1[R99*]), and Arg82
(Krp1[R82*]). Translation of these truncated proteins in extract
resulted in translocation into microsomes and presequence cleavage to
generate markers that are appropriate for different prosequences.
|
|
Mutations that disrupted the internal cluster of basic residues
(without affecting the primary cleavage site) did not prevent
cleavage
of the prosequence at the primary site (Fig.
3A, lanes
2 and 3). This
is not unexpected, but it indicates that cleavage
of the prosequence at
Lys-Arg102 does not require prior cleavage
at the internal site. We
confirmed this by using a high-percentage
acrylamide gel to demonstrate
that the cleaved prosequence was
indeed full-length and comigrated with
the product obtained by
translating Krp1[R102*] in extract (Fig.
3B, lane 1). Krp1[R102*]
is a shortened form of Krp1 that is
truncated immediately after
Arg102 to give a product that contains
residues 24 to 102 (inclusive)
of full-length Krp1 (the first 23 residues are removed as the
presequence).
Changing the primary cleavage site from the normal Lys-Arg motif to
Lys-Lys also had little effect on processing at this position
(Fig.
3A,
lanes 4 through 6) (see below), but converting the dibasic
motif at the
primary site to Lys-Ala inhibited cleavage at this
position and allowed
us to investigate processing at other sites
within the prosequence
(Fig.
3A, lanes 7 through 9). A mutant
possessing the normal Lys-Arg82
motif at the internal site was
cleaved at this position to generate a
catalytic fragment that
starts at residue 83 (Fig.
3A, lane 7; the
identity of this product
was confirmed by radiosequencing [not
shown]) and a prosequence
that corresponds to residues 24 to 82 of
Krp1 (Fig.
3B, lane 2).
The catalytic fragment underwent a second
cleavage to generate
a product with an apparent
Mr that is between those of products
cleaved at
the primary site and products cleaved at the internal
site. This
cleavage must occur after the cleavage at Lys-Arg82,
as we see only one
product on the high-percentage gel (Fig.
3B,
lane 2); we would not
expect to detect the small peptide produced
from the catalytic fragment
by this second cleavage. The identity
of this second product is
discussed below.
Removing the dibasic motifs at both the primary and internal sites
greatly reduced processing of the proprotein (Fig.
3A,
lanes 8 and 9),
and only limited cleavage was observed after prolonged
incubation in
extract (Fig.
3A, lane 10). The catalytic fragment
produced by this
cleavage comigrated with the product generated
by the second cleavage
of Krp1[KA102] (Fig.
3A, lane 7), whereas
the prosequence
migrated between those produced after digestion
at the primary and
internal sites (Fig.
3B, lane 3). Krp1 contains
three Arg residues
between the internal and primary cleavage sites
(Fig.
1), and we
suspected that this product was generated by
cleavage at one of these
residues. Given that Kex2 can cleave
substrates at Pro-Arg motifs
(
53), we expected this cleavage
to occur after Pro-Arg97 and
were surprised that sequencing showed
that cleavage occurs after
Trp-Arg99 (Fig.
4). This site is clearly
less accessible in full-length proKrp1 than in the protein that
has
already been cleaved at Lys-Arg102.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
Prosequence cleavage between the primary and internal
sites. Krp1 (shown as Krp1[KR82][KR102] to emphasize the
sequences at the primary and internal sites) and
Krp1[IA82][KA102] mRNAs were translated in
Xenopus egg extract for 1 h in the presence of
[3H]leucine, and the products were separated by SDS-PAGE
before being transferred to a PVDF membrane. The positions of proteins
were identified by autoradiography, and the sections of the membrane
corresponding to the proteins were excised and subjected to cycle
sequencing. The amount of [3H]leucine in each cycle was
determined by scintillation counting and compared to the protein
sequences. The cleavage sites are indicated by black arrows, and shaded
arrows indicate the positions of mutated sites in
Krp1[IA82][KA102].
|
|
Primary cleavage of the prosequence is intramolecular.
As Krp1
does not normally cleave a substrate that contains a Lys-Lys motif
(8), the apparently efficient cleavage of mutant Krp1
proteins containing Lys-Lys102 (Fig. 3A, lanes 4 through 6) appeared to
contradict our earlier observation that the primary cleavage of the
prosequence is autocatalytic. We addressed this issue by combining the
Lys-Lys102 change with the Ser371-to-Ala mutation that inactivates the
enzyme. To avoid potential problems with cleavage at the internal site,
we also introduced the Ile-Ala82 change that completely inhibits
cleavage at this site (Fig. 3, lanes 9 and 10). As expected,
translation of Krp1[IA82][KK102]S371A mRNA in
Xenopus egg extract generated a single product
corresponding to the proenzyme (Fig. 2, lane 5). However, in contrast
to the result with proKrp1S371A (Fig. 2, lanes 2 and 3), active
Krp1 was unable to remove the prosequence from
proKrp1[IA82][KK102]S371A when it was presented in
trans (Fig. 2, lane 6). This difference is consistent
with our previous work showing that Krp1 has a strong preference for
substrates containing Lys-Arg motifs rather than Lys-Lys motifs
(8). Therefore, the efficient cleavage of the Lys-Lys102
site when it was present as part of an enzymatically active form of
Krp1 (Fig. 2, lane 4, and 3, lanes 4 through 6) suggests that initial
cleavage of the prosequence is not an intermolecular event but, rather,
an intramolecular event normally.
C-terminal requirements for prosequence cleavage.
There have
been several studies to investigate the role of C-terminal sequences in
the maturation of kexins (15, 17, 47). Much of this work has
focused on the role of the P domain, a conserved region of about 150 residues that is found just C terminal of the catalytic domain and is
present only in subtilisin-like enzymes implicated in proteolytic
processing rather than degradation (12, 15). Disruption of
the P domain blocks the production of active enzyme, and although the
nature of the defect has not always been determined, it appears that
this region is required for efficient cleavage of the prosequence
(15). We therefore investigated the role of the C terminus
in the maturation of Krp1.
Stop codons were introduced at various positions along the
krp1 open reading frame, and mRNAs corresponding to the
various
truncated enzymes were translated in egg extract (Fig.
5). Truncations
that successively removed
the cytoplasmic tail (Krp1[K696*]),
the transmembrane domain
(Krp1[R667*]), and the Ser/Thr-rich domain
(Krp1[Y611*])
had no effect on cleavage of the prosequence (Fig.
5, lanes 4 through
6), which appeared to occur as efficiently
as it did in the full-length
protein (Fig.
5, lane 1) (full-length
Krp1 contains 709 residues). In
contrast, truncating Krp1 at or
N terminal of Ser590 dramatically
inhibited cleavage of the prosequence
(Fig.
5, lanes 2 and 3); only
partial processing was observed
even after prolonged incubation (Fig.
5, lanes 7 and 8). It should
be noted that for brevity, Fig.
5 contains
only the results for
Krp1[W578*] and Krp1[S590*] and that
we obtained very similar
results with a series of mutants truncated
between these two points
(Krp1[L580*], Krp1[L582*],
Krp1[W583*], Krp1[G584*], and Krp1[E585*]).
Further truncations between Ser590 and Tyr611 are needed to more
closely define the region required for efficient cleavage of the
prosequence.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 5.
C-terminal requirements for prosequence cleavage. Krp1
mRNA and mRNAs from truncated forms of Krp1 were translated in
Xenopus egg extract for 1 h in the presence of
[3H]leucine before being analyzed by SDS-PAGE (lanes 1 to
6). mRNAs from Krp1[W578*], Krp1[S590*], and
Krp1[Y611*] (included to provide a convenient reference point
between processed and unprocessed proteins) were also translated for
24 h before analysis (lanes 7 to 9). The positions of molecular
weight markers (in thousands) are shown on the left.
|
|
Activation of Krp1 in Xenopus egg extract.
Autoproteolytic cleavage of the prosequence indicates that Krp1 becomes
active soon after synthesis in Xenopus egg extract. However,
we were unable to detect any proteolytic activity in such samples when
fluorogenic substrates were used under conditions that supported
cleavage by Krp1 prepared from yeast membranes (not shown). The
inability of these samples to process substrates presented in
trans is reminiscent of earlier studies in which furin
activation was shown to require events that occurred after the cleavage
of the prosequence at the primary site (31, 49). We
therefore investigated whether egg extract would support the additional
steps required to activate Krp1. To simplify interpretation of the
results, we translated Krp1 mRNA for 1 h in the presence of
[3H]leucine before adding cycloheximide to inhibit any
further translation. Incubation was continued for various periods, and
samples were analyzed by SDS-PAGE and assayed for the ability to cleave
an appropriate substrate (Fig. 6). Little
or no Krp1 activity was detected in early samples, but considerable
activity was detected in samples incubated for 15 and 23 h. As
translation had been inhibited by the addition of cycloheximide, this
activity was not the result of increased production of Krp1; it was due
to activation of the enzyme.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 6.
Activation of Krp1 in Xenopus egg extract.
Krp1 mRNA was translated in Xenopus egg extract for 1 h
in the presence of [3H]leucine. Cycloheximide was added
(final concentration, 2 mM) to inhibit any further translation, and
incubation was continued for various times (as indicated) before
samples were analyzed by SDS-PAGE. The amount of Krp1 in each sample
was determined by using a PhosphorImager (Molecular Dynamics) with
ImageQuant software, and equivalent amounts of protein were assayed for
the ability to cleave the fluorogenic substrate
Boc-Arg-Thr-Lys-Arg-MCA. Activity was determined under initial rate
conditions and is expressed relative to the maximum activity observed
in the experiment. The positions of molecular weight markers (in
thousands) are shown to the left of the gel.
|
|
Activation of Krp1 appears to correlate with a significant decrease in
the mobility of the protein. Such heterogeneous changes
often accompany
the addition of carbohydrates to proteins. We
investigated whether Krp1
underwent O glycosylation or whether
there was further elaboration of
the N-linked sugars that are
added soon after translocation into
membranes (Fig.
7). The tripeptide
(acetyl)-Asn-Tyr-Thr-(amide) competes with proteins for the
transfer
of sugar chains from their dolichol lipid carrier
(
23) and has
previously been shown to completely inhibit N
glycosylation of
Krp1 in egg extract (
8). It did not,
however, prevent the decrease
in the mobility of Krp1 (Fig.
7A), which
suggests that this modification
is not due to the elaboration of
N-linked sugars. As no equivalent
inhibitor of O glycosylation was
available, we sought to investigate
this indirectly by exploiting the
ability of glycoproteins to
bind to concanavalin A (ConA)-Sepharose
(Fig.
7B). ConA preferentially
binds to

-mannopyranosyl and

-glycopyranosyl residues but recognizes
a somewhat wider range of
both N- and O-linked sugars; therefore,
the binding of Krp1 to
ConA-Sepharose in the absence of N glycosylation
is reasonable evidence
that this protein is O glycosylated. In
contrast, the Map2 protein does
not become O glycosylated and
fails to bind ConA when N glycosylation
is inhibited. The most
likely location for O glycosylation of Krp1 is
the Ser/Thr-rich
domain located just proximal to the transmembrane
domain (19 Ser
or Thr residues between positions 619 and 647)
(
9). Such domains
become O glycosylated in other
transmembrane proteins, including
Kex2 (
10). The suggestion
that the heterogeneity we observed
was due to O glycosylation of this
region was provided by the
Krp1[Y611*] mutant described above.
This mutant is truncated just
N terminal of the Ser/Thr-rich domain.
Although it became N glycosylated
soon after translation, it did not
undergo any further modifications
during extended incubation in extract
(Fig.
5, lane 9). The Krp1[Y611*]
mutant also demonstrated that
the correlation between O glycosylation
and activation is not
obligatory and that like Kex2 (
11,
15),
Krp1 can become
active without being O glycosylated (Table
1).
It appears therefore that O
glycosylation merely provides a convenient
marker for some other event
that is essential for the activation
of Krp1.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 7.
Krp1 undergoes both N glycosylation and O glycosylation
in Xenopus egg extract. Krp1 mRNA was translated in egg
extract for 1 h in the presence of [3H]leucine
before a 23-h chase (cycloheximide was added after 1 h to inhibit
further translation). Translations were also performed in the presence
of the tripeptide (acetyl)-Asn-Tyr-Thr-(amide) (NYT; final
concentration, 10 mM) to inhibit N glycosylation (8, 23).
(A) Samples were analyzed by SDS-PAGE. (B) Samples from extract
(prepared in the presence and absence of NYT) were diluted in binding
buffer (20 mM Tris [pH 7.5], 0.5 M NaCl, 0.5% Triton X-100) and
allowed to bind to ConA-Sepharose in the same buffer. Unbound materials
were removed by extensive washing, and beads were resuspended in
electrophoresis sample buffer and analyzed by SDS-PAGE. T, total sample
prior to incubation with ConA-Sepharose; B, material remaining bound to
beads after being washed. Map2, a protein that undergoes N
glycosylation but not O glycosylation (8, 19), was included
as a control for the inhibition of N glycosylation by NYT and for the
specificity of beads. The positions of molecular weight markers (in
thousands) are shown on the left.
|
|
To discover which mutants could become active in the extract, we
translated the appropriate mRNAs for 1 h before adding
cycloheximide
to inhibit further translation and allowing the
incubation to
continue for a further 23 h. Equivalent
amounts of Krp1 and various
mutant enzymes were assayed for
activity (Table
1). As expected,
the active-site mutants
Krp1S371A and Krp1[IA82][KK102]S371A were
inactive,
but all of the other mutants developed at least some
activity. Removing
the cytoplasmic tail, transmembrane domain,
and Ser/Thr-rich region
(e.g., Krp1[Y611*]) had only a small effect
on the activation
process, but truncating Krp1 at or near the
C-terminal end of the P
domain (e.g., Krp1[S590*]) had a more
dramatic effect. These
mutants attained less than 10% of the activity
associated with the
full-length protein. Mutating the primary
cleavage site from Lys-Arg102
to Lys-Ala102 prevented proper cleavage
of the prosequence and caused
at least a fivefold reduction in
activity. These mutants were cleaved
at Trp-Arg99 (Fig.
4), and
there appeared to be no difference in
activation between constructs
which were cleaved only at this site
(e.g., Krp1[KA82][KA102])
and those which were initially
cleaved at Lys-Arg82 (e.g., Krp1[KR82][KA102]).
It was
perhaps not surprising to find that incorrect cleavage
of the
prosequence affected activity, but we were more surprised
to discover
that the nature of the cleaved prosequence appears
to influence
subsequent activation of the enzyme. Indeed, only
one mutant
(Krp1[KR82][KK102]) developed activity that was similar
to
that of Krp1. We considered it to be perhaps significant that
this was
the only construct in which the internal cleavage site
was the same as
that in the wild-type enzyme, and we wondered
whether cleavage at this
site was required for activation of the
enzyme. To investigate this, we
examined the prosequences produced
from a selection of constructs and
found that activation did appear
to correlate with internal cleavage of
the prosequence (Fig.
8).
Internal
cleavage of the Krp1 prosequence appeared to be coincident
with its
activation (Fig.
8, lane 1), whereas the prosequence
initially cleaved
from the Krp1[IA82] mutant did not undergo secondary
cleavage at
the internal site (Fig.
8, lane 2) and the enzyme
did not become active
(Table
1). As there is no apparent difference
in the initial cleavage
of the prosequence from these two enzymes
(both are cleaved at the
primary site of Lys-Arg102) and they
contain identical catalytic
domains, we suggest that the inability
of the mutant to become active
is due to its failure to cleave
the internal site of the initially
cleaved prosequence. In the
other two mutants whose results are shown
in Fig.
8, mutation
of the primary cleavage site leads to the
production of shortened
prosequences that do not undergo subsequent
cleavage but are also
unable to prevent the enzymes from becoming at
least partially
active.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 8.
Internal cleavage of the initially cleaved prosequence
is required for activation of Krp1. Krp1 mRNA and mRNAs from various
Krp1 mutants that lack the normal basic motifs at either the primary or
internal site were translated in Xenopus egg extract for
1 h in the presence of [3H]leucine. (Top) Samples
were analyzed by SDS-PAGE on a high-percentage gel. (Bottom) Duplicate
samples were treated in the same way except that cycloheximide was
added after 1 h (to inhibit translation) and incubation was
continued for a further 15 h before samples were analyzed. Mutant
forms of Krp1 with stop codons introduced immediately after Arg102
(Krp1[R102*]), Arg99 (Krp1[R99*]), and Arg82
(Krp1[R82*]) were translated in extract to provide appropriate
markers and aid in the interpretation of results.
|
|
The prosequence interacts with Krp1 in vivo.
Our studies with
Xenopus egg extract helped us to define events in the
maturation of Krp1, and although we believe that our findings reflect
events in this fission yeast, we sought to confirm this in a more
physiological environment. Unfortunately, such studies are complicated
by the fact that S. pombe appears to require a tightly
controlled level of Krp1 activity and that both the loss and
overexpression of the enzyme are deleterious to cell growth
(8). It was not possible therefore to simply repeat the in
vitro analysis in vivo. We took the alternative approach of expressing
various Krp1 prosequence constructs in otherwise wild-type yeast cells
(Table 2). These cells contained the
normal chromosomal copy of the krp1 gene, and cells
transformed with pREP3X vector alone had a doubling time of about
4 h. The expression of Krp1[KR82][KR102][R102*]
(which has the Lys-Arg motif at both the primary and internal cleavage
sites and terminates immediately after Arg102 to generate a product
that is equivalent to the prosequence expected from the initial
cleavage of wild-type Krp1) had little effect on cell growth, but the
expression of Krp1[KA82][KR102][R102*] (same as
Krp1[KR82][KR102][R102*] but with a noncleavable
internal site) caused a dramatic decrease in the rate of growth. Such a decrease in the growth rate would be expected if
Krp1[KA82][KR102][R102*] inhibited Krp1. The
specificity of this interaction was supported by our finding that
Krp1[KA82][Y100*] did not affect cell growth. This
construct generates a prosequence that lacks the C-terminal Lys-Arg
motif of the normal prosequence, which suggests that these residues are
important for the apparent inhibition of Krp1 by Krp1[KA82][KR102][R102*].
 |
DISCUSSION |
Using an in vitro system prepared from Xenopus eggs, we
investigated events in the activation of Krp1, the only member of the
kexin family of proprotein convertases present in the fission yeast
S. pombe. Krp1 is a type I membrane protein that is
synthesized as a preproenzyme. The presequence is removed during
translocation into the ER, where the proKrp1 becomes N glycosylated.
Cleavage of the prosequence at Lys-Arg102 is autocatalytic and can
occur intermolecularly, although we suspect it is normally
intramolecular because mutants containing Lys-Lys102 are cleaved much
more efficiently than would be expected from the relative inability of
Krp1 to cleave Lys-Lys-containing substrates in trans
(8). Indeed, an inactive form of Krp1 that contains the
S371A mutation as well as the Lys-Lys102 motif was not cleaved by
incubation with Krp1. A closer analysis of the kinetics of this
processing event will be required to prove that prosequence cleavage is
intramolecular. Prosequence cleavage was unaffected in mutants lacking
the cytoplasmic tail, the transmembrane domain, and even the
Ser/Thr-rich region near the C terminus of the protein but was
inhibited by deletions that affect the P domain. Even though it was
initially identified as a homologous region C terminal to the catalytic
domain, mutational analyses have demonstrated a functional role for the
P domain in kexin maturation (6, 15, 17). Although our
results are similar to those obtained with the P domain of Kex2
(15), they do not allow us to identify the end of the P
domain as accurately as was possible in the earlier study. The high
level of sequence similarity between the two enzymes in this region
suggests that the different results are probably due to differences in
the assays used to monitor the effects of these mutations rather than
to any significant difference in the precise role of the P domain.
Cleavage of the prosequence at the primary site was necessary but not
sufficient for activation of Krp1, and despite the ability of the
enzyme to cleave its own prosequence, it was initially unable to
process substrates presented in trans. The enzyme became fully active only upon further incubation in extract. The relationship between activation and O glycosylation appeared to be fortuitous, however, as a truncated form of Krp1 that failed to become O
glycosylated did become active. It seems more likely that this is
simply a convenient marker for another event that is necessary for
activation. Our results do not precisely define this event but show
that activation is accompanied by internal cleavage of the initially
cleaved prosequence and, furthermore, that mutant enzymes in which this
cleavage is prevented fail to become activated. These results are
consistent with a model in which the cleaved prosequence remains
noncovalently associated with the catalytic domain of Krp1 and acts as
an autoinhibitor. Inhibition is relieved by cleavage of the prosequence
by Krp1 at the internal site, and the enzyme is then able to process
other substrates. This model is further supported by the finding that overexpression of a noncleavable prosequence reduced the growth rate of
yeast cells, presumably through inhibition of Krp1. The reduction in
growth rate and presumably therefore the interaction with Krp1 require
the presence of the two basic residues (Lys-Arg102) at the C terminus
of the prosequence.
Our results are similar to those recently reported for the maturation
of furin (1). The furin prosequence is removed
autoproteolytically but remains associated with the mature part of the
enzyme and acts as a potent inhibitor. Inhibition is relieved by
cleavage of the prosequence at the internal site. Indeed, the only
significant difference between furin and Krp1 appears to be the trigger
that allows cleavage of the inhibitory prosequence. The activation of
furin requires its movement from the ER to the Golgi complex and
appears to be triggered by the decreased pH and increased Ca2+ associated with this transport. These changes are
thought to reduce the interaction between furin and its prosequence and
allow the enzyme to cleave the inhibitory peptide at the internal site. Such compartment-specific activation of furin may prevent inappropriate cleavage of substrates in the ER or may be required to allow the enzyme
sufficient time to adopt its correct conformation. As predicted by this
model, inhibiting the transport of furin to the Golgi complex by adding
an ER retrieval signal prevents the enzyme from becoming active
(31). This ER-retained form of furin can be activated in
vitro by mimicking the changes normally associated with transport to
the Golgi complex (1). In contrast, despite using conditions
similar to those used for furin (1), we were unable to
promote the activation of Krp1 by changing the pH and/or Ca2+ concentration (not shown). This may suggest that the
activation of the yeast enzyme does not require its export from the ER.
Indeed, we sometimes observed activation of Krp1 in Xenopus
egg extract in the absence of O glycosylation (not shown), but we
cannot yet discriminate between Krp1 molecules that remain in the ER
and those that are transported to the Golgi complex but are not O glycosylated. It is perhaps significant that the addition of an ER
retrieval signal to Kex2 does not prevent its activation
(5).
A possible molecular explanation for the pH-dependent activation of
furin is ionization of the histidine residues near the C terminus of
the prosequence (1). These may influence the interaction
between the prosequence and the catalytic domain and may be affected by
the transport of the enzyme from the ER to the Golgi complex. Changes
in the ionization state of these residues may reduce the stability of
the prosequence-enzyme complex and trigger activation of the enzyme.
The positions of these histidine residues are conserved in almost all
of the kexins identified in higher eukaryotes but are absent from both
Krp1 and Kex2, which is consistent with evidence that activation of the
yeast enzymes, like that of the bacterial enzymes, is not pH dependent.
Many members of the kexin family contain a cluster of basic residues
that can be aligned with the internal site of furin and Krp1
(41), and cleavage at this site may be a common feature in
the activation of these other enzymes. However, not all kexins contain
this second site. If the inhibitory prosequence is therefore a common
theme in this family, it will be necessary to invoke other mechanisms
of degradation; it is perhaps significant that furin can be activated
by digestion with trypsin (1).
Our results have gone some way to defining the events required for the
activation of Krp1, but they have revealed little about how these
events are controlled at the molecular level. For example, how does the
prosequence remain associated with the enzyme and what events are
required to trigger dissociation? It will also be interesting to
discover whether the prosequence physically dissociates from the Krp1
before being inactivated by cleavage at the internal site. We are using
Xenopus egg extract to address these and other questions and
are complementing our in vitro work with in vivo analysis.
 |
ACKNOWLEDGMENTS |
We thank Kevin Davis and Glenn Matthews for expert technical
assistance during this work.
This work was supported by a studentship from the Biotechnology and
Biological Sciences Research Council (ref. 94305555) (D.P.) and by
grants from the Cancer Research Campaign (ref. Sp1972). J.D. is a
Lister Institute Research Fellow.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biological Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom. Phone: 01203 524204. Fax: 01203 523701. E-mail:
PDJT{at}dna.bio.warwick.ac.uk.
 |
REFERENCES |
| 1.
|
Anderson, E. D.,
J. K. Van Slyke,
C. D. Thulin,
F. Jean, and G. Thomas.
1997.
Activation of furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage.
EMBO J.
16:1508-1518[Medline].
|
| 2.
|
Brenner, C., and R. S. Fuller.
1992.
Structural and enzymatic characterisation of a purified prohormone processing enzyme: secreted, soluble KEX2 protease.
Proc. Natl. Acad. Sci. USA
89:922-926[Abstract/Free Full Text].
|
| 3.
|
Bruzzaniti, A.,
K. Goodge,
P. Jay,
S. A. Taviaux,
M. H. C. Lam,
P. Berta,
T. J. Martin,
J. M. Moseley, and M. T. Gillespie.
1996.
C8, a new member of the convertase family.
Biochem. J.
314:727-731.
|
| 4.
|
Bryan, P.,
L. Wang,
J. Hoskins,
S. Ruvinov,
S. Strausberg,
P. Alexander,
O. Almog,
G. Gilliland, and T. Gallagher.
1995.
Catalysis of a protein folding reaction: mechanistic implications of the 2.0 Å structure of the subtilisin-prodomain complex.
Biochemistry
34:10310-10318[Medline].
|
| 5.
|
Chaudhuri, B.,
S. E. Latham, and C. Stephan.
1992.
A mutant Kex2 enzyme with a C-terminal HDEL sequence releases correctly folded human insulin-like growth factor-1 from a precursor accumulated in the yeast endoplasmic reticulum.
Eur. J. Biochem.
210:811-822[Medline].
|
| 6.
|
Creemers, J. W. M.,
R. J. Siezen,
A. J. M. Roebroek,
T. A. Y. Ayoubi,
D. Huylebroeck, and W. J. Van de Ven.
1993.
Modulation of furin-mediated proprotein processing activity by site-directed mutagenesis.
J. Biol. Chem.
268:21826-21834[Abstract/Free Full Text].
|
| 7.
|
Creemers, J. W. M.,
M. Vey,
W. Schäfer,
T. A. Y. Ayoubi,
A. J. M. Roebroek,
H.-D. Klenk,
W. Garten, and W. J. M. Van de Ven.
1995.
Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum.
J. Biol. Chem.
270:2695-2702[Abstract/Free Full Text].
|
| 8.
|
Davey, J.,
K. Davis,
Y. Imai,
M. Yamamoto, and G. Matthews.
1994.
Isolation and characterisation of krp, a dibasic endopeptidase required for cell viability in the fission yeast Schizosaccharomyces pombe.
EMBO J.
13:5910-5921[Medline].
|
| 9.
|
Elhammer, A. P.,
R. A. Poorman,
E. Brown,
L. L. Maggiora,
J. H. Hoogerheide, and F. J. Kezdy.
1993.
The specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase as inferred from a database of in vivo substrates and from the in vitro glycosylation of proteins and peptides.
J. Biol. Chem.
268:10029-10038[Abstract/Free Full Text].
|
| 10.
|
Fuller, R. S.,
A. J. Brake, and J. Thorner.
1989.
Intracellular targeting and structural conservation of a prohormone-processing endoprotease.
Science
246:482-485[Abstract/Free Full Text].
|
| 11.
|
Fuller, R. S.,
A. Brake, and J. Thorner.
1989.
Yeast prohormone processing enzyme (KEX2 gene product) is a calcium-dependent serine protease.
Proc. Natl. Acad. Sci. USA
86:1434-1438[Abstract/Free Full Text].
|
| 12.
|
Fuller, R. S.,
C. Brenner,
P. Gluschankof, and C. A. Wilcox.
1991.
The yeast prohormone-processing Kex2 protease, an enzyme with specificity for paired basic residues, p. 205-214. In
H. Jörnvall, J.-O. Höög, and A.-M. Gustavsson (ed.), Methods in protein sequence analysis.
Birkhäuser, Berlin, Germany.
|
| 13.
|
Gallagher, T.,
G. Gilliland,
L. Wang, and P. Bryan.
1995.
The prosegment subtilisin BPN' complex: crystal structure of a specific `foldase.'
Structure
3:907-914[Medline].
|
| 14.
|
Germain, D.,
F. Dumas,
T. Vernet,
Y. Bourbonnais,
D. Y. Thomas, and G. Boileau.
1992.
The pro-region of the Kex2 endoprotease of Saccharomyces cerevisiae is removed by self-processing.
FEBS Lett.
299:283-286[Medline].
|
| 15.
|
Gluschankof, P., and R. S. Fuller.
1994.
A C-terminal domain conserved in precursor processing proteases is required for intramolecular N-terminal maturation of pro-Kex2 protease.
EMBO J.
13:2280-2288[Medline].
|
| 16.
|
Goodman, L. J., and C. M. Gorman.
1994.
Autoproteolytic activation of the mouse prohormone convertase mPC1.
Biochem. Biophys. Res. Commun.
201:795-804[Medline].
|
| 17.
|
Hatsuzawa, K.,
M. Nagahama,
S. Takahashi,
K. Takada,
K. Murakami, and K. Nakayama.
1992.
Purification and characterisation of furin, a Kex2-like processing endoprotease, produced in Chinese hamster ovary cells.
J. Biol. Chem.
267:16094-16099[Abstract/Free Full Text].
|
| 18.
|
Ikemura, H., and M. Inouye.
1988.
In vitro processing of pro-subtilisin produced in Escherichia coli.
J. Biol. Chem.
263:12959-12693[Abstract/Free Full Text].
|
| 19.
|
Imai, Y., and M. Yamamoto.
1994.
The fission yeast mating pheromone P-factor: its molecular structure, gene structure and physiological activities to induce gene expression and G1 arrest in the mating partner.
Genes Dev.
8:328-338[Abstract/Free Full Text].
|
| 20.
|
Kiefer, M. C.,
J. E. Tucker,
R. Joh,
K. E. Landsberg,
D. Saltman, and P. J. Barr.
1991.
Identification of a second subtilisin-like protease gene in the fes/fps region of chromosome 15.
DNA Cell Biol.
10:757-769[Medline].
|
| 21.
|
Korner, J.,
J. Chun,
D. Harter, and R. Axel.
1991.
Isolation and functional expression of a mammalian prohormone processing enzyme, murine prohormone convertase-1.
Proc. Natl. Acad. Sci. USA
88:6834-6838[Abstract/Free Full Text].
|
| 22.
|
Krieg, P. A., and D. A. Melton.
1984.
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.
Nucleic Acids Res.
12:7057-7070[Abstract/Free Full Text].
|
| 23.
|
Lau, J. T.,
J. K. Welply,
P. Shenbagamartin,
F. Naider, and W. J. Lennarz.
1983.
Substrate recognition by oligosaccharyl transferase.
J. Biol. Chem.
258:15255-15260[Abstract/Free Full Text].
|
| 24.
|
Leduc, R.,
S. S. Molloy,
B. A. Thorne, and G. Thomas.
1992.
Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage.
J. Biol. Chem.
267:14304-14308[Abstract/Free Full Text].
|
| 25.
|
Li, Y., and M. Inouye.
1994.
Autoprocessing of prothiolsubtilisin E in which active-site serine 211 is altered to cysteine.
J. Biol. Chem.
269:4169-4174[Abstract/Free Full Text].
|
| 26.
|
Li, Y.,
Z. Hu,
F. Jordan, and M. Inouye.
1995.
Functional analysis of the propeptide of subtilisin E as an intramolecular chaperone for protein folding.
J. Biol. Chem.
270:25127-25132[Abstract/Free Full Text].
|
| 27.
|
Lindberg, I.
1994.
Evidence for cleavage of the PC1/PC3 pro-segment in the endoplasmic reticulum.
Mol. Cell. Neurosci.
5:263-268[Medline].
|
| 28.
|
Matthews, G., and A. Colman.
1991.
A highly efficient, cell-free translation/translocation system prepared from Xenopus eggs.
Nucleic Acids Res.
19:6405-6412[Abstract/Free Full Text].
|
| 29.
|
Matthews, G.,
K. I. J. Shennan,
A. J. Seal,
N. A. Taylor,
A. Colman, and K. Docherty.
1994.
Autocatalytic maturation of the prohormone convertase PC2.
J. Biol. Chem.
269:588-592[Abstract/Free Full Text].
|
| 30.
|
Maundrell, K.
1993.
Thiamine-repressible expression vectors pREP and pRIP for fission yeast.
Gene
123:127-130[Medline].
|
| 31.
|
Molloy, S. S.,
L. Thomas,
J. K. Van Slyke,
P. E. Stenberg, and G. Thomas.
1994.
Intracellular trafficking and activation of the furin proprotein convertase: localisation to the TGN and recycling from the cell surface.
EMBO J.
13:18-33[Medline].
|
| 32.
|
Moreno, S.,
A. Klar, and P. Nurse.
1991.
An introduction to molecular genetic analysis of the fission yeast Schizosaccharomyces pombe.
Methods Enzymol.
194:795-823[Medline].
|
| 33.
|
Nakagawa, T.,
M. Hosaka,
S. Torii,
T. Watanabe,
K. Murakami, and K. Nakayama.
1993.
Identification and functional expression of a new member of the mammalian Kex2-like processing endoprotease family its striking structural similarity to PACE4.
J. Biochem.
113:132-135[Abstract/Free Full Text].
|
| 34.
|
Nakayama, K.,
W.-S. Kim,
S. Torii,
M. Hosaka,
T. Nakagawa,
J. Ikemizu,
T. Baba, and K. Murakami.
1992.
Identification of the fourth member of the mammalian endoprotease family homologous to the yeast Kex2 protease.
J. Biol. Chem.
267:5897-5900[Abstract/Free Full Text].
|
| 35.
|
Power, S. D.,
R. M. Adams, and J. A. Wells.
1986.
Secretion and autoproteolytic maturation of subtilisin.
Proc. Natl. Acad. Sci. USA
83:3096-3100[Abstract/Free Full Text].
|
| 36.
|
Roebroek, A. J. M.,
I. G. L. Pauli,
Y. Zhang, and W. J. M. Van de Ven.
1991.
cDNA sequence of a Drosophila melanogaster gene, dfur1, encoding a protein structurally related to the subtilisin-like proprotein processing enzyme furin.
FEBS Lett.
289:133-137[Medline].
|
| 37.
|
Roebroek, A. J. M.,
J. W. M. Creemers,
I. G. L. Pauli,
U. Kurzikdumke,
M. Rentrop,
E. A. F. Gateff,
J. A. M. Leunissen, and W. J. M. Van de Ven.
1992.
Cloning and functional expression of dfurin2, a subtilisin-like proprotein processing enzyme of Drosophila melanogaster with multiple repeats of a cysteine motif.
J. Biol. Chem.
267:17208-17215[Abstract/Free Full Text].
|
| 38.
|
Schägger, H., and G. von Jagow.
1987.
Tricine-sodium dodecyl sulfate polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.
Anal. Biochem.
166:369-379.
|
| 39.
|
Shennan, K. I. J.,
N. A. Taylor,
J. L. Jermany,
G. Matthews, and K. Docherty.
1995.
Differences in pH optima and calcium requirements for maturation of the prohormone convertases PC2 and PC3 indicate different intracellular locations for these events.
J. Biol. Chem.
270:1402-1407[Abstract/Free Full Text].
|
| 40.
|
Siezen, R. J., and J. A. M. Leunissen.
1997.
Subtilases: the superfamily of subtilisin-like serine proteases.
Protein Sci.
6:501-523[Medline].
|
| 41.
|
Siezen, R. J.,
J. A. M. Leunissen, and U. Shinde.
1995.
Homology analysis of the propeptides of subtilisin-like serine proteases (subtilases), p. 233-255. In
U. Shinde, and M. Inouye (ed.), Intramolecular chaperones and protein folding. R. G.
Landes Company, Austin, Tex.
|
| 42.
|
Silen, J. L.,
D. Frank,
A. Fujishige,
R. Bone, and D. A. Agard.
1989.
Analysis of prepro- -lytic protease expression in Escherichia coli reveals that the pro region is required for activity.
J. Bacteriol.
171:1320-1325[Abstract/Free Full Text].
|
| 43.
|
Smeekens, S. P., and D. F. Steiner.
1990.
Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2.
J. Biol. Chem.
265:2997-3000[Abstract/Free Full Text].
|
| 44.
|
Smeekens, S. P.,
A. S. Avruch,
J. Lamendola,
S. J. Chan, and D. F. Steiner.
1991.
Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans.
Proc. Natl. Acad. Sci. USA
88:340-344[Abstract/Free Full Text].
|
| 45.
|
Steiner, D. F.,
S. P. Smeekens,
S. Ohagi, and S. J. Chan.
1992.
The new enzymology of precursor processing endoproteases.
J. Biol. Chem.
267:23435-23438[Free Full Text].
|
| 46.
|
Tanguy-Rougeaua, C.,
M. Weslowski-Louvel, and H. Fukuhara.
1988.
The Kluyveromyces lactis KEX1 gene encodes a subtilisin-like serine proteinase.
FEBS Lett.
234:464-470[Medline].
|
| 47.
|
Taylor, N. A.,
K. I. J. Shennan,
D. F. Cutler, and K. Docherty.
1997.
Mutations within the propeptide, the primary cleavage site or the catalytic site, or deletion of C-terminal sequences, prevents secretion of proPC2 from transfected COS-7 cells.
Biochem. J.
321:367-373.
|
| 48.
|
Van den Ouweland, A. M. V.,
H. L. P. Duijnhoven,
G. D. Keizer,
L. C. J. Dorsser, and W. J. M. Van de Ven.
1990.
Structural homology between the human Fur gene product and the subtilisin-like protease encoded by yeast KEX-2.
Nucleic Acids Res.
18:664[Free Full Text].
|
| 49.
|
Vey, M.,
W. Schäfer,
S. Berghöfer,
H.-D. Klenk, and W. Garten.
1994.
Maturation of the trans-Golgi network protease furin: compartmentalisation of propeptide removal, substrate cleavage and COOH-terminal truncation.
J. Cell Biol.
127:1829-1842[Abstract/Free Full Text].
|
| 50.
|
Vindrola, O., and I. Lindberg.
1992.
Biosynthesis of the prohormone convertase-mPC1 in AtT-20 cells.
Mol. Endocrinol.
6:1088-1094[Abstract/Free Full Text].
|
| 51.
|
Wilcox, C. A., and R. S. Fuller.
1991.
Posttranslational processing of the prohormone-cleaving Kex2 protease in the Saccharomyces cerevisiae secretory pathway.
J. Cell Biol.
115:297-307[Abstract/Free Full Text].
|
| 52.
|
Zhu, X.,
Y. Ohta,
F. Jordan, and M. Inouye.
1989.
Pro-sequence of subtilisin can guide the refolding of denatured subtilisin in an intermolecular process.
Nature
339:483-484[Medline].
|
| 53.
|
Zhu, Y. S.,
X. Y. Zhang,
C. P. Cartwright, and D. J. Tipper.
1992.
Kex2-dependent processing of yeast K1 killer preprotoxin includes cleavage at ProArg-44.
Mol. Microbiol.
6:511-520[Medline].
|
Mol Cell Biol, January 1998, p. 400-408, Vol. 18, No. 1
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rabah, N., Gauthier, D., Wilkes, B. C., Gauthier, D. J., Lazure, C.
(2006). Single Amino Acid Substitution in the PC1/3 Propeptide Can Induce Significant Modifications of Its Inhibitory Profile toward Its Cognate Enzyme. J. Biol. Chem.
281: 7556-7567
[Abstract]
[Full Text]
-
He, Y., Sugiura, R., Ma, Y., Kita, A., Deng, L., Takegawa, K., Matsuoka, K., Shuntoh, H., Kuno, T.
(2006). Genetic and functional interaction between Ryh1 and Ypt3: two Rab GTPases that function in S. pombe secretory pathway. GENES CELLS
11: 207-221
[Abstract]
[Full Text]
-
Cho, S. K., Hofmann, S. L.
(2004). pdf1, a Palmitoyl Protein Thioesterase 1 Ortholog in Schizosaccharomyces pombe: a Yeast Model of Infantile Batten Disease. Eukaryot Cell
3: 302-310
[Abstract]
[Full Text]
-
Heusipp, G., Young, G. M., Miller, V. L.
(2001). HreP, an In Vivo-Expressed Protease of Yersinia enterocolitica, Is a New Member of the Family of Subtilisin/Kexin-Like Proteases. J. Bacteriol.
183: 3556-3563
[Abstract]
[Full Text]
-
Zhong, M., Munzer, J. S., Basak, A., Benjannet, S., Mowla, S. J., Decroly, E., Chretien, M., Seidah, N. G.
(1999). The Prosegments of Furin and PC7 as Potent Inhibitors of Proprotein Convertases. IN VITRO AND EX VIVO ASSESSMENT OF THEIR EFFICACY AND SELECTIVITY. J. Biol. Chem.
274: 33913-33920
[Abstract]
[Full Text]
-
Boudreault, A., Gauthier, D., Lazure, C.
(1998). Proprotein Convertase PC1/3-related Peptides Are Potent Slow Tight-binding Inhibitors of Murine PC1/3 and Hfurin. J. Biol. Chem.
273: 31574-31580
[Abstract]
[Full Text]